Beruflich Dokumente
Kultur Dokumente
LIM ITE D
May 30, 2016
TTKH:SECL:GJ:076:16
BSE Limited
53
507747
31
Dear Sirs,
Re
We are forwarding herewith the Audited Financial Results for the year ended 31stMarch,2016,
Board of Directors of
along with the Audit Report, Form A and Declaration taken on record by the
the Company at their Meeting held today at Chennai'
Kindly take the above document on record.
Thanking you
Yours faithfullY
@ry
(S KALYANARAMAN)
Director t Wholetime Secretary
Encl.
a/a
&
STATEMENT OF AUDITED FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED
3tst MARCH,2O16
(Rs. in lakhs)
3 months
sl.
Particulars
No
ended
Corresponding 3
Preceding 3
months
Current Year Previous
months
Year ended
ended in the
ended
ended
previous
year
(31t12120151
Unaudited
Unaudited
EI
(31/03/20't 5) (31/03/2016)
Unaudited
Audited
(31/03/2015)
Audited
11956.76
12682.63
11169.66
51480.01
48254 73
3.44
395.42
13078.05
20.35
11190.01
406.54
51886.55
37.93
48292.66
864.48
4602.53
703.45
4214.03
3547 .32
4703.78
19525.48
3138.64
19063.03
-472.26
196.01
14.02
-145.66
-256.89
2124 46
265.35
1182.43
2334.84
11163.61
2038.9s
146.08
1925.65
2196.54
11970.24
1899.30
247 22
1355.70
2102.47
10535.19
u79.A7
7685.67
9046.90
48560.29
7228.44
613.98
7961.59
8202.96
45951.75
796.59
1107.8'1
653.82
3326.26
2340.9',1
160.52
124.94
201.40
957.',1l
1232.75
855.22
Finance Costs
114 14
71
842.97
1161.66
758.85
3552.7 4
2633.46
0.00
0.00
0.00
0.00
000
842.97
'1161.66
758.85
3552.74
2633.46
302.05
1286.22
1017.94
I
I
(31/03/2016)
Expenses
(a) Cost of materials consumed
(b) Purchases of Stock-in-trade
(c) Changes in lnventories of finished goods, workin-progress and stock-in-trade
(d) Emplovee benefits exDense
(e) Deprecration and amortisation expense
(f) l\,4arketino Expenses
(q) Other expenses
Total Expenses
Profit / (Loss) from Operations before Other
lncome, Finance Costs and Exceptional ltems
r960.20
1025.O1
720.71
11-21
4
5
Other lncome
Profit / (Loss) from Ordinary Activities before
656.78
3885.47
.09
2997.69
364 23
(5i6)
B
10
11
12
13
14
16
Exceptional ltems
(13r14r15)
248.70
594.27
729,'t'l
456.80
2266.52
1615.52
0.00
594.27
0.00
729.',|1
0.00
456.80
0.00
2266.52
1515.52
N,A.
N,A.
N.A.
N,A,
N,A.
N,A.
594.27
729.1',|
456.80
000
N,A.
r,l.A.
2266.52
N,A
1615.52
17
1B
19
(i)
Basic
(b) Oiluted
19
(
ii)
776.60
776.60
776.60
776.60
12403 18
10604.00
7.65
5.88
765
588
29.19
29.19
20.80
20.80
5.88
29.19
s.88
10
20 80
20.80
776.60
7.65
7.65
9.39
9.39
,o
NqIES;
The above results have been reviewed / audited by the Statutory Auditors of the Company, reviewed by the Audit Committee
and approved by the Board of Directors of the Company at their Meeting held on 30th May, 2016, at Chennai.
(2)
The Other Operating lncome for the current year includes non-recurring income of Rs.3.25 crores (Net) received during the
Third Quarter towards product development trials conducted for a Third Party.
(3)
The Board has recommended a Dividend ofRs.5.00per Equity ShareofRs.l0/- each (50%) forthe financial yearended3lst
(1
March.2016.
(4)
The figures for the three months' ended 3'1st lMarch, 2016 are the balancing figures betlveen the audited figures in respect of
the full flnancial year and the published year to date figures upto the nine months of the relevant financial year
period's / year's figures have been regrouped and reclassified, wherever necessary to conform to the current
period's / yea/s presentation.
(6) This
Statement is also available on the website of BSE Limited (www.bseindia.com) and National Stock Exchange of lndia
Limited (www. nseindia.com) and also on the website of the Company (www.ttkhealthcare.com).
st.
Particula rs
No.
Shareholde6' Funds
(a) Share Capital
(b)
Minority lnterest
4. Non.Current Liabilities
3
77659830
77659830
1284460632
1105045079
1362120462
1182704909
Long-Term Borrowings
10609632
159836379
50680409
22258779
102451721
96564362
Long-Term Provisions
163741762
278659520
219531330
223012201
3337 40251
300688951
899302473
724732163
46839759
42166265
r499413813
1290599580
3025276037
275r964009
Rs.
(b)
(d)
As at 31/03/2015
Rs.
(a)
5.
As at 31/03/2016
ASSETS
Non-Current Assets
(a) Fixed Assets
1070704147
97
5720790
118926017
115245388
(0
1'189630124
1090956'178
Current Assets
(a) Current lnvestments
101337000
1337000
(b) lnventories
414526066
37377 437 5
466202804
444125976
771629049
772998464
81951034
68762016
1835645913
1660997831
302s276037
2751964009
(0
For TTK H e
Place:
Chennai
Date:
Lfy*t'"neo
T T RAGHUNATHAN
EXECUTIVE VICE CHAIRMAN
&
Offico
3 months
st.
Particula rs
No
ended
Correspondlng 3
Previous 3
months
Current year Previous
months
ended ln the
ended
Y6ar ended
6nded
previous
year
lE?rEnr,lEllE[@El
Unaudited
,|
S
a
b
c
d
e
c
e
a
b
c
d
e
Total Ca
Add
dinS
't485.06
'1436.95
836
13.11
12682.63
'H169.66
000
0.00
11169.66
832 52
ments
750.10
lElr,E77,lHlE'rfillfEl
IME?F.IIIIIIMIiI
157.75
186.58
842.97
1161.66
31/03/2016
-84.67
1457.55
-380.24
9634.58
-39.08
As on
31t12t20't5
478.72
165.39
758.
As on
3t/03/2015
@39
reEIU
I@EI@
3117 82
393.43
1 15.64
915.63
31.89
688.94
3552.7
As on
26275.27
1979.64
5712.28
2510.23
301.89
-543.65
1236.83
26.25
3531.55
364 23
533.86
2633.46
As on
31t0312015
1048.98
1228.77
9704.46
31to3t2o',t6
-84.67
1457 .55
-380.24
9634.58
-39.08
10588.14
1048.98
'1'186.33
-124.86
2766s.54
2251.06
457 4.41
-IEEE@re
As on
ment Liabilities
Pharmaceuticals
l\,4ed cal Devices
Consumer Products
Foods
Others
ital E
6119.70
468.26
12682.63
880.67
Capital Employed
ment Assets - S
11956.76
6702 B5
496.73
r@rcre
rerc-EE
rereETg
reEE,re
III@IE@I@
Pharmaceuticals
Medical Devices
Consumer Products
Foods
Others
Total
Less : lnterest
Less : Unallocable Expenses
J.
Unaudited
re
@-r.r{rflEE[[IEr,r,6!@@l
I@
@
rc
re
II@
E!@@
re
rcre
E!@@
6260.29
31103t201s
ent Revenue:
Pharmaceuticals
lredical Devices
Consumer Products
Foods
Others
Total
Less : lnter S ment Revenue
Net Sales / lncome from
tions
Segment Results: lProflt (+) / Loss (-)
before tax and lnterest from each
a
b
Unaudited
-253.16
-253.'16
7700.97
-21.10
9704.46
6221.81
6342 02
6782.55
6221 .81
6782.55
16809.9s
16381.67
16487.01
16809.95
16487.01
NOIEST
1.
Segments have been identified in line with the Accounting Standard on Segment Reporting (AS-17) considering th
organisation structure and the differential risks and returns of these segments.
Segment Sales is net of Excise Duty related to the Sales of own manufactured goods for the current as well as fo
the previous periods.
3.
*
,l
a
*
Consumer Products comprise of marketing and distribution of EVA Range of Cosmetics, Good Home range
Scrubbers, Air Freshners, etc., (Own Brands) and also trading of Branded Condoms.
Foods comprise of manufacturing and marketing of Food Products.
"Others" include Printing and Publashing of Maps and Atlases.
The segment-wise revenue, results and capltal employed figures relate to respective amounts directly identifiabl
each of the segments. The unallocable expenditure includes expenses incurred on common services at
corporate level and also those expenses not identiflable to any specific segment.
The previous period's / yeafs figures have been regrouped and reclassified, wherever necessary to conform to the
current period's / yeals presentation.
{
Place: Chennai
Oate
: Ma 30 2016
T T RAGHUNATHAN
EXECUTIVE VICE CHAIRMAN
INDEPENOENT AUDITORS
REPORT TO THE BOARD OF OIRECTORS OF TTK HEALTHCARE LIMITED
1
Standards prescribed under Section 133 of the Companies Act, 2013, as applicable and
other accounting principles generally accepted in lndia. Our responsibility is to express an
opinion on the Statement.
2
We conducted our audit in accordance with the Standards on Audating issued by the lnstitute
of Chartered Accountants of lndia. Those Standards require that we comply with ethical
requirements and plan and perform the audit to obtain reasonable assurance about whether
the Statement is free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and the
disclosures in the Statement. The procedures selected depend on the auditor's judgement,
including the assessment of the risks of material misstatement of the Statement, whether due
to fraud or error. ln making those risk assessments, the auditor considers internal control
relevant to the Company's preparation and fair presentation of the Statement in order to
design audit procedures that are appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the Company's internal control. An audit also
of the
We believe that the audit evidence we have obtained is sufficient and appropriate to provide
a basis for our audit opinion.
3.
ln our opinion and to the best of our information and according to the explanations given to
us, the Statement, read with Note 4:
(i)
(ii)
gives a true and fair view in conformity with the aforesaid Accounting Standards and
other accounting principles generally accepted in lndia of the net profit and other
financial information of the Company for the year ended 31"i March, 2016
:\
%*o
vt,
I'
oG.ilMl
600
m4
DAC
This Statement includes the results for the Quarter ended 3lstMarch, 2016 being the
balancing figure between audited figures in respect of the full financial year and the
published year to date figures up to the Third Quarter of the current financial year
which were
subject to limited review by us.
Chartered Accountants
F.R. No.000063S
C--t" (
gr) r
N SRIDHARAN
PROPRIETOR
Mem
Place
Date
Chartered Accountants
C N SRINIVASAN
PARTNER
Membership No.18205
Ghennai
May 30, 2016
ot*{Al
G00
00r
TTK Healthcare
LIMITED
FORM A
As per Regulations 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements)
Regulations , 2015
1
year ended
3.
(i) Unmodified
(ii) Matter of Emphasis -
Proposed Scheme of
Amalgamation between M/s TTK Protective
Devices Limited (formerly known as TTK-LlG
Limited) and its Wholly Owned Subsidiary M/s TSL
Frequency of Observation
5.
Signed by-
k/
I
(T T RAGHUNATHAN)
Exe cutia e V i ce Ch airman
G .u'f,4'
cFo
(B V K DURGA
Senior Vice President - Finance
(./
(N SRIDHARAN)
Proprietor
na/p
4tyel& 99.
__)
(c N SRTNTVASAN)
Partner
M/s S Viswanathan LLP
a,il^, --'ffiEf,(eol
Chairman
Audit Committee
Regd. Office : No. 6, Cathedral Road, Chennai - 600 086' INDIA
Phone :91-44-28116106 - 08, Fax :9144-28116387
tt*
TTK Healthcare
LIfUITED
TTKH:SECL:cJ:078:16
BSE Limited
Code
3153
5077 47
Dear Sirs,
Ref:
(i)
We hereby declare that the Statutory Auditors of the Company have given their Unmodified
Opinion to the Audited Financial Statements of the Company for the year ended 31"r lvlarch, 2016.
Their Report also includes an "Emphasis of Matters" relating to the proposed Scheme of
Amalgamation between M/s TTK Protective Devices Limited (formerly known as TTK-LIG Limited)
and its Wholly Owned Subsidiary M/s TSL Techno Services Limited (TSL) [Transferor Companies]
with the Company lTransferee Company] which is awaiting the sanction of the Hon'ble High Court
of Judicature at Madras.
Please take the above information on record.
Thanking you
Yours faithfully
For TTK Hea
ate
ited
(T T RAGHUNATHAN)
V ice Chairman
Execut iz,e